虚拟现实改善功能性消化不良症状:一项随机、双盲、假对照先导研究结果
该先导研究将功能性消化不良患者按2:1随机分为主动虚拟现实(VR)组与假VR组,用PAGI-SYM量表评估2周内症状变化。主动VR组PAGI-SYM评分数值改善更大(平均差值-0.7,P<0.001),假VR组平均差值-0.4(P=0.032);主动VR改善除下腹痛外的所有PAGI-SYM子量表,假VR仅改善烧心/反流和恶心/呕吐。半数患者报告非严重不良事件,仅1例因不良事件退出。
要点
- 主动VR组PAGI-SYM评分平均差值-0.7(P<0.001),假VR组-0.4(P=0.032)。
- 主动VR改善除下腹痛外所有PAGI-SYM子量表,假VR仅改善烧心/反流和恶心/呕吐。
- 半数患者报告非严重不良事件,仅1例因不良事件退出,VR总体安全。
核心结论
- VR是安全的,并使功能性消化不良患者症状获得显著改善。
- 需要更大规模的试验。
研究设计与样本
- 随机、双盲、假对照先导研究,患者按2:1随机分为主动VR组与假VR组。
- 使用胃肠道疾病患者评估-症状严重程度指数(PAGI-SYM)在2周内评估症状。
主要发现
- 主动VR组PAGI-SYM评分平均差值-0.7(P<0.001),假VR组平均差值-0.4(P=0.032)。
- 主动VR使除下腹痛外的所有PAGI-SYM子量表均显著改善,假VR仅改善烧心/反流和恶心/呕吐。
- 半数患者报告非严重不良事件,仅1例因不良事件退出研究。
局限性
- 原文结论指出需要更大规模的试验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: We investigated the efficacy and safety of virtual reality (VR) for functional dyspepsia. METHODS: Patients were randomized 2:1 between active vs sham VR. Symptoms were assessed using the Patient Assessment of Gastrointestinal Disorders-Symptom Severity Index (PAGI-SYM) over 2-week. RESULTS: Patients in the active VR group had greater numerical improvement in PAGI-SYM scores (mean difference -0.7; P < 0.001) compared with sham VR (mean difference -0.4; P = 0.032). Active VR led to significant improvements for all PAGI-SYM subscales, except lower abdominal pain, whereas sham only improved heartburn/regurgitation and nausea/vomiting. Half of the total patients reported nonserious adverse effects, although only 1 patient withdrew from the study because of adverse effects. DISCUSSION: VR is safe and results in significant symptom improvement in functional dyspepsia. Larger trials are warranted.
引用
- Cangemi DJ, Montenegro M, Spiegel BMR, et al. Virtual Reality Improves Symptoms of Functional Dyspepsia: Results of a Randomized, Double-Blind, Sham-Controlled, Pilot Study. Am J Gastroenterol. 2023. PMID: 37655713. doi:10.14309/ajg.0000000000002492
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。